Top Markets
#1 Pons Pons +10.72%
#2 StonkBroker StonkBroker +7.70%
#3 龙虾 (Lobster) 龙虾 (Lobster) +7.11%
#4 Siacoin Siacoin +6.63%
#5 Story Story +5.66%
#6 Cash Cat Cash Cat +5.40%
#7 Unit Pump Unit Pump +4.76%
#8 Pump.fun Pump.fun +4.76%
#9 Status Status +4.75%
#10 Seeker Seeker +4.04%
Coin of the day
Pons Pons
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
EirGenix Inc. EirGenix Inc.

EirGenix Inc.

6589
Rang in Aktien #14111
EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions... EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions as a contract development and manufacturing organization (CDMO) with operations spanning both domestic and international markets. The company offers a comprehensive range of services, encompassing cell line creation, process optimization, analytical testing and quality control, and current Good Manufacturing Practice (cGMP) compliant production utilizing both mammalian and microbial expression systems. They also specialize in services related to antibody-drug conjugates (ADCs). Beyond its service offerings, EirGenix is actively engaged in developing several therapeutic candidates. This pipeline includes EG12014/EGI014, a Trastuzumab biosimilar intended for cancer therapy, which has reached the biologics license application (BLA) submission stage. Other oncology-focused developments are EG1206A, a Pertuzumab biosimilar currently in Phase I clinical trials; EG13074, in preclinical development; and TSY0110(EG12043), an antibody-drug conjugate also in preclinical stages. Additionally, the company is advancing EG12021, a Bevacizumab biosimilar for cancer treatment, and EG62054, another biosimilar, both in preclinical development. In addition to its core activities, EirGenix manufactures and distributes a rapid antigen test for COVID-19, as well as the CRM197 carrier protein under the designation EG74032.
Aktienkurs
$1.46
Zuletzt synchronisiert: 2026-07-28
Marktkapitalisierung
$435.25M
Veränderung (1 Tag)
-2.34%
Veränderung (1 Jahr)
-26.63%
Land
TW
Handel EirGenix Inc. (6589)

Kategorie

Healthcare
Dividendenrendite-Verlauf für EirGenix Inc. (6589)
Dividendenrendite (TTM) von EirGenix Inc. (Aktienkürzel: 6589) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für EirGenix Inc. (6589) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH